Cargando…

Approaching China's pharmaceutical market : a fundamental guide to clinical drug development /

This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a strat...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Lu, Ming Q. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham, Switzerland : Springer, 2015.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn915343744
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu|||unuuu
008 150803s2015 sz a ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d GW5XE  |d IDEBK  |d AZU  |d YDXCP  |d OCLCF  |d COO  |d CDX  |d EBLCP  |d OCLCQ  |d LVT  |d VT2  |d UAB  |d Z5A  |d OCLCQ  |d ESU  |d IOG  |d REB  |d U3W  |d OCLCQ  |d CEF  |d OCLCA  |d WYU  |d MERER  |d UKMGB  |d AU@  |d UKAHL  |d OCLCQ  |d OCLCO  |d DCT  |d ERF  |d OCLCQ  |d WURST  |d OCLCA  |d AJS  |d OCLCQ  |d OCLCO  |d NLW  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL  |d OCLCQ 
015 |a GBB953057  |2 bnb 
016 7 |a 019301920  |2 Uk 
019 |a 972003529  |a 985042399  |a 1005752648  |a 1011999525  |a 1022019483  |a 1026438214  |a 1048170799  |a 1066466520  |a 1110860490  |a 1112597547  |a 1119458082 
020 |a 9783319155760  |q (electronic bk.) 
020 |a 3319155768  |q (electronic bk.) 
020 |a 331915575X  |q (print) 
020 |a 9783319155753  |q (print) 
020 |z 9783319155753 
024 7 |a 10.1007/978-3-319-15576-0  |2 doi 
029 1 |a AU@  |b 000058374924 
029 1 |a AU@  |b 000060385322 
029 1 |a NLGGC  |b 395262232 
029 1 |a UKMGB  |b 019301920 
035 |a (OCoLC)915343744  |z (OCoLC)972003529  |z (OCoLC)985042399  |z (OCoLC)1005752648  |z (OCoLC)1011999525  |z (OCoLC)1022019483  |z (OCoLC)1026438214  |z (OCoLC)1048170799  |z (OCoLC)1066466520  |z (OCoLC)1110860490  |z (OCoLC)1112597547  |z (OCoLC)1119458082 
037 |a com.springer.onix.9783319155760  |b Springer Nature 
043 |a a-cc--- 
050 4 |a HD9672.C5 
060 4 |a QV 33 JC6 
072 7 |a BUS  |x 070000  |2 bisacsh 
072 7 |a TDCW  |2 bicssc 
082 0 4 |a 338.4761510951  |2 23 
049 |a UAMI 
245 0 0 |a Approaching China's pharmaceutical market :  |b a fundamental guide to clinical drug development /  |c Ming Q. Lu, editor. 
264 1 |a Cham, Switzerland :  |b Springer,  |c 2015. 
300 |a 1 online resource :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file 
347 |b PDF 
504 |a Includes bibliographical references and index. 
588 0 |a Vendor-supplied metadata. 
505 0 |a Preface -- Law, Regulation and Guidance -- Pharmaceutical Intellectual Property Rights in China -- The China Food and Drug Administration (CFDA) -- Registration -- Guidance for Application Materials/Booklets (Chemical) -- New Investigational Drug Application -- Clinical Development of Investigational New Drug -- Strategic Drug Development in China and Surrounding Countries -- Drug Safety Monitoring and Reporting Systems in China -- In Vitro Diagnostic Development -- Index. 
520 |a This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a strategic path and bridge the gap for regulatory and legal differences between China and the Western world. For a better understanding of the drug registration process, it explores the differences between the China Food and Drug Administration (CFDA)--including its regulations and registration procedures--and those of the Western world. The volume discusses disparities between China's application requirements compared to Western standards to make it easier for companies to prepare their application packages. It also provides detailed commentary on CFDA guidelines in reference to clinical trial (IND) and market application (NDA) requirements. Overall, this book offers guidance for Western companies aspiring to expand into China's pharmaceutical market in hopes that they may gain a fundamental understanding of its rules and complexities in order to ensure a smooth transition and prevent future issues. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Pharmaceutical industry  |z China. 
650 0 |a Drug development  |z China. 
650 2 |a Legislation, Drug 
650 2 |a Pharmacy Administration 
650 2 |a Drug Discovery 
651 2 |a China 
650 6 |a Industrie pharmaceutique  |z Chine. 
650 6 |a Médicaments  |x Développement  |z Chine. 
650 7 |a BUSINESS & ECONOMICS  |x Industries  |x General.  |2 bisacsh 
650 7 |a Drug development  |2 fast 
650 7 |a Pharmaceutical industry  |2 fast 
651 7 |a China  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJcrd4RjtCBk4wfMhTwwG3 
653 0 0 |a biomedische wetenschappen 
653 0 0 |a biomedicine 
653 0 0 |a farmacologie 
653 0 0 |a pharmacology 
653 1 0 |a Medicine (General) 
653 1 0 |a Geneeskunde (algemeen) 
700 1 |a Lu, Ming Q.,  |e editor. 
758 |i has work:  |a Approaching China's Pharmaceutical Market (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCYXTQXqV7G3GQDW6mvGm3P  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Printed edition:  |z 9783319155753 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3567973  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH31355433 
938 |a Coutts Information Services  |b COUT  |n 32290594 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3567973 
938 |a EBSCOhost  |b EBSC  |n 1046667 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis32290594 
938 |a YBP Library Services  |b YANK  |n 12552613 
994 |a 92  |b IZTAP